Zobrazeno 1 - 4
of 4
pro vyhledávání: '"M. D. C. Castro Villegas"'
Autor:
M. D. C. Castro Villegas, M. L. Ladehesa Pineda, Juan L. Garrido-Castro, I. C. Aranda-Valera, R. Ortega Castro, E. Collantes Estevez, C. Gonzalez-Navas, F. Torres Vidal
Publikováno v:
Annals of the Rheumatic Diseases. 79:892.1-893
Background:Spinal mobility is an important assessment outcome in axial spondyloarthritis (axSpA). Until now, conventional metrology (Schober test, lateral flexion, BASMI, …) has been used to assess spinal mobility, however, new technologies have be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2dcce71f297408fd5f6acea687f9647
https://doi.org/10.1136/annrheumdis-2020-eular.2137
https://doi.org/10.1136/annrheumdis-2020-eular.2137
Autor:
Cristina Fernández-Carballido, J.F. García Llorente, X. Juanola-Roura, E. De Miguel, M. D. C. Castro Villegas, B. Joven-Ibáñez, C. Tornero, C. Urrego-Laurín, María Luz García-Vivar, Eva Galindez
Publikováno v:
Annals of the Rheumatic Diseases. 79:754.2-754
Background:Longitudinal studies about the change from non-radiographic axial Spondyloarthritis (nr-axSpA) to r-axSpA (radiographic axial Spondyloarthritis) are scarce but show a 9-10% progression rate over 2 years (1-2) and a 24% progression rate ove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0135f9414181f47a2be877a27c051236
https://doi.org/10.1136/annrheumdis-2020-eular.5450
https://doi.org/10.1136/annrheumdis-2020-eular.5450
Autor:
M.C. Abalos-Aguilera, M. D. C. Castro Villegas, M. Á. Puche Larrubia, Pozo Laura, G. C. Juan Luis, J. M. Sequí-Sabater, A. Escudero Contreras, R. Ortega Castro, G. G. Ignacio, C. López-Medina, Eduardo Collantes-Estevez, M. Ladehesa Pineda, I. C. Aranda-Valera
Publikováno v:
Annals of the Rheumatic Diseases. 79:752.1-752
Background:The ASAS Health Index (ASAS-HI) questionnaire, a tool that measures the impact of the disease on the health in patients with Spondyloarthritis (SpA), has been recently validated. However, there are still no studies evaluating the utility o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8df9f4306e0b404be11ffd82806f1025
https://doi.org/10.1136/annrheumdis-2020-eular.5640
https://doi.org/10.1136/annrheumdis-2020-eular.5640
Autor:
M Cárdenas Aranzana, S de la Fuente Ruiz, D Ruiz Vílchez, R. Ortega Castro, J Calvo Guitiérrez, M Romero Gomez, P Font Ugalde, M. D. C. Castro Villegas, E Colllantes Estévez
Publikováno v:
Eur J Hosp Pharm
BACKGROUND: Dose optimisation (dose reduction or dose spacing) is a therapeutic strategy applied in patients with rheumatoid arthritis (RA) who have managed to maintain clinical remission. This strategy reduces the frequency of adverse effects and pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff30816e02788203965ed2010f5f8e48
https://doi.org/10.1136/ejhpharm-2018-eahpconf.242
https://doi.org/10.1136/ejhpharm-2018-eahpconf.242